DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) enters 2025 on the cusp of generating product revenues from its relationship with Proliant. Initially, commercialization ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Its growing portfolio of mRNA capping analogs includes the award-winning CleanCap® M6, mRNA raw materials (nucleotides and other IVT enzymes including wild-type T7 RNA polymerase), advanced scale ...

RNA technology is an emerging field that exploits the unique structural and functional properties of RNA to build nanoscale structures and regulate complex biological systems (Stewart, 2024). RNA has ...

The limitations of conventional pesticides have raised the demand for innovative and sustainable solutions for plant protection. RNA Interference (RNAi) triggered by dsRNA has evolved as a promising ...